SCUBE1 inhibitors represent a class of compounds that specifically target and modulate the function of SCUBE1, a member of the Signal Peptide-CUB-EGF-like (SCUBE) protein family. SCUBE1 is a glycoprotein that plays an essential role in cellular signaling pathways and protein-protein interactions. Structurally, SCUBE1 contains multiple domains, including signal peptides, CUB (Complement Subcomponents C1r/C1s, Uegf, Bmp1) domains, and epidermal growth factor (EGF)-like repeats, which contribute to its function in mediating extracellular interactions. SCUBE1 is involved in various biological processes, including cell adhesion and migration, acting as a co-receptor in developmental and homeostatic signaling cascades. Inhibitors of SCUBE1 are designed to interfere with its binding capacity, typically by targeting its interaction domains, such as the CUB or EGF-like domains, thereby disrupting the downstream cellular pathways dependent on SCUBE1.
The molecular mechanisms of SCUBE1 inhibition often revolve around the disruption of its interaction with other ligands or receptors in the extracellular matrix, which is critical for maintaining cellular homeostasis and signal transduction. These inhibitors may possess diverse chemical structures but often exhibit a high degree of specificity for SCUBE1's functional domains, ensuring that they selectively impair its ability to participate in signaling networks without broadly affecting other proteins. SCUBE1 inhibitors are also useful for studying the role of this protein in cellular processes like angiogenesis and cellular matrix remodeling, offering valuable insights into how SCUBE proteins contribute to tissue morphogenesis and structural integrity. By selectively modulating SCUBE1, researchers gain a deeper understanding of how the manipulation of such glycoproteins can impact complex biological processes at the cellular and molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Inhibits the Hedgehog signaling pathway, potentially affecting SCUBE1-related processes. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $80.00 $96.00 | 1 | |
A specific inhibitor of the Hedgehog pathway, used in cancer therapy. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
Inhibits Wnt/β-catenin signaling, potentially affecting SCUBE1-related processes. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
A γ-secretase inhibitor, used to block Notch signaling. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $74.00 $119.00 | 33 | |
Inhibits the epidermal growth factor receptor (EGFR), potentially affecting related signaling. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inhibits the TGF-β receptor, affecting related signaling pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Inhibits autophagy and lysosomal degradation, potentially affecting protein turnover related to SCUBE1. | ||||||